Anticoagulation in COVID-19.pdf (361.6 kB)
Download file

Anticoagulation in COVID-19

Download (361.6 kB)
journal contribution
posted on 07.02.2022, 14:04 by Bassam Atallah, Saad I Mallah, Wael Almahmeed
As hospitals worldwide continue to admit an influx of coronavirus disease 2019 (COVID-19) patients, the puzzling pathogenesis behind the witnessed mortality rates is progressively being pieced together. Aside from the established respiratory involvement, the cardiac system has recently been implicated, albeit with controversial mechanisms. New data from cohort studies and autopsies suggest a potential role for coagulopathy in COVID-19. Although the exact mechanism may likewise remain controversial, several clinical implications are now imperative for discussion.

History

Comments

The original article is available at https://academic.oup.com/

Published Citation

Atallah B, Mallah SI, AlMahmeed W. Anticoagulation in COVID-19. Eur Heart J Cardiovasc Pharmacother. 2020;6(4):260-261

Publication Date

30 April 2020

PubMed ID

32352517

Department/Unit

  • RCSI Bahrain

Publisher

Oxford University Press

Version

  • Published Version (Version of Record)